Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Healthcare Services — Diagnostics & Imaging. Per the activity note to the FY2024 annual report, the company provides laboratory and medical services, imports medical equipment, installs it, and wholesales pharmaceutical products.
Group parent — controls 1 company · ownership
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|
| 3,995 | 4,095 | 5,301 | 5,090 | 5,374 | +7.7% | |
| Total COGS | 2,788 | 3,533 | 2,164 | 2,230 | 1,985 | -8.1% |
| Gross Profit | 1,207 | 562 | 3,136 | 2,861 | 3,388 | +29.4% |
| Gross Margin | 30.2% | 13.7% | 59.2% | 56.2% | 63.1% | |
| 189 | 349 | 2,901 | 2,391 | 2,809 | +96.4% | |
| EBITDA | 1,019 | 213 | 235 | 470 | 580 | -13.1% |
| EBITDA Margin | 25.5% | 5.2% | 4.4% | 9.2% | 10.8% | |
| Total D&A | 57 | 62 | 255 | 254 | 249 | +44.8% |
| EBIT / Operating Income | 962 | 151 | 19 | 216 | 331 | -23.4% |
| Total Interest Income | 0 | 0 | 0 | 3 | 1 | -64.1% |
| Total Interest Expense | 0 | 0 | 51 | 90 | 98 | +38.3% |
| 157 | 0 | 136 | 0 | 0 | nmf | |
| Profit Before Tax | 805 | 151 | 66 | 128 | 233 | -26.6% |
| Total Income Tax | 0 | 0 | 0 | 3 | 0 | |
| Net Profit / (Loss) | 805 | 151 | 339 | 125 | 233 | -26.6% |
| Net Margin | 20.2% | 3.7% | 6.4% | 2.5% | 4.3% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →